Javier Salvador Bofill

机构：Hospital Universitario Virgen del Rocío · ORCID：0000-0003-3043-4398

发表论文 70 篇 · 总被引 884 次 · h-index 13

代表论文

• Abemaciclib, Palbociclib, and Ribociclib in Real-World Data: A Direct Comparison of First-Line Treatment for Endocrine-Receptor-Positive Metastatic Breast Cancer (2023 · International Journal of Molecular Sciences · 被引 76)
• Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer (2026 · New England Journal of Medicine · 被引 66)
• Sacituzumab govitecan (SG) + pembrolizumab (pembro) vs chemotherapy (chemo) + pembro in previously untreated PD-L1–positive advanced triple-negative breast cancer (TNBC): Primary results from the randomized phase 3 ASCENT-04/KEYNOTE-D19 study. (2025 · Journal of Clinical Oncology · 被引 59)
• Targeting the Tumor Microenvironment in Breast Cancer: Prognostic and Predictive Significance and Therapeutic Opportunities (2023 · International Journal of Molecular Sciences · 被引 34)
• A Cross-Sectional Validation Study of Camry EH101 versus JAMAR Plus Handheld Dynamometers in Colorectal Cancer Patients and Their Correlations with Bioelectrical Impedance and Nutritional Status (2024 · Nutrients · 被引 14)
• Predictive factors for complete pathologic response in luminal breast cancer: impact of ki67 and HER2 low expression (2024 · Therapeutic Advances in Medical Oncology · 被引 8)